🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalSouth Korea Ozempic availability — what worked for you? Page 3

South Korea Ozempic availability — what worked for you?

andrew_nyc Fri, Mar 6, 2026 at 2:58 AM 11 replies 925 viewsPage 3 of 3
MikeFit_NJ
Senior Member
1,567
6,543
Apr 2024
New Jersey
Mar 10, 2026 at 12:42 AM#11
Dr.AddMedPHL said:
If two explanations both fit, the useful question is which one predicts something the other does not.

Agreed, though "tolerable" needs defining. A dose you tolerate by eating almost nothing is not tolerated, it is being paid for somewhere else — usually in lean mass, sometimes in adherence three months later.

49 22LeilaHI, marcus_mpls, DeniseRN_TPA and 46 others
Reply Quote Save Share Report
wanda_boise
Member
412
1,890
Aug 2024
Boise, ID
Mar 10, 2026 at 8:09 AM#12
HPLC_Greg said:
The mechanism that matters here is not stomach emptying, it is central.

Thank you for spelling out the reasoning rather than just the conclusion. Taking it to my next appointment.

50 23marco_milano, pam_columbus, nick_SD_fit and 47 others
Reply Quote Save Share Report
steph_laguna
Member
234
1,123
Nov 2024
Laguna Beach, CA
Mar 10, 2026 at 3:36 PM#13
Dr.AddMedPHL said:
If two explanations both fit, the useful question is which one predicts something the other does not.

I will push back on the "any working dose is fine" framing. The maintenance evidence sits overwhelmingly at the top studied dose, and the extension data shows regain tracking dose reduction rather than tracking stopping. Holding low is reasonable; pretending it is evidentially equivalent is not.

I would rather be corrected than agreed with, if it comes to it.

1 24carl_compliance
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
Dr.RaviCardio
VIP Member
2,890
15,678
Jan 2024
New York, NY
Mar 10, 2026 at 11:03 PM#14

The figures, for anyone assembling their own picture. One habit that pays for itself: post the method alongside the number. A figure without its method cannot be checked, and an unchecked figure is how this community accumulates folklore.

Ask again with the specifics and you will get a better answer than this one.

2 0hans_munich, jason_sac26
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Mar 11, 2026 at 6:30 AM#15

Moderator note: two posts asking for a source have been merged into one. Please search the thread before asking again.

3 1PurityPaulOR, MaxMetOK, MounjBrad
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register